Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. The Company works to enable a healthier world by supporting their customers to deliver new and innovative medicines that help treat a wide range of diseases. Lonza achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Lonza's unparalleled breadth of offerings enables their customers to commercialize their discoveries and innovations in the healthcare industry. Founded in 1897 in the Swiss Alps, today, Lonza operates across five continents. With approximately 16,000 employees (full-time equivalent), the company comprise high-performing teams and individual talent that make a meaningful difference to it's own business, as well as to the communities in which the company operate. The company generated sales of CHF 5.4 billion with a CORE EBITDA of CHF 1.7 billion in Full-Year 2021.
